Immune to Cancer: The CRI Blog



Video: Watch These Facebook Live Updates on Cancer Immunotherapy with CRI Experts

 Recently, Cancer Research Institute CEO and Director of Scientific Affairs Jill O’Donnell-Tormey, PhD, appeared in two informative Facebook Live broadcasts to discuss current developments and challenges in cancer immunotherapy.

Last week, during the Second International Cancer Immunotherapy Conference (CICON16), O’Donnell-Tormey moderated a Q&A panel with renowned cancer immunology experts Elizabeth Jaffee, MD, of Johns Hopkins Medicine and Philip Greenberg, MD, of Fred Hutchinson Cancer Research Center.

Earlier this week, O’Donnell-Tormey sat down with Business Insider’s pharmaceutical and biotech reporter Lydia Ramsey to share the latest advancements in cancer immunotherapy, and highlight CRI’s role in pioneering and leading this vital new field of cancer treatment.

We are grateful for the continued opportunities to provide updates on cancer immunotherapy’s progress and promising future.

Read more:

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.